News | Lung Cancer | October 05, 2017

CompleWare and Vida Announce Joint Marketing Agreement for Respiratory Trials

Vida will combine its pulmonary imaging software suite with CompleWare’s application for clinical trial data capture and management

CompleWare and Vida Announce Joint Marketing Agreement for Respiratory Trials

October 5, 2017 — CompleWare and Vida recently announced a joint marketing agreement promoting complementary respiratory services. Their partnership will deploy a high-end pulmonary platform and excellence in clinical trial management, with precision, ISO-certified core lab imaging. 

CompleWare software and contract research organization (CRO) services will facilitate complete respiratory development programs. This will provide specialized experts to support global respiratory trials. VIDA and CompleWare will provide precision lung imaging informatics, delivered through core lab imaging services (Precision Services) and interactive software (VIDA|vision). This solution spans the care cycle, from detection through treatment across a range of pulmonary diseases: COPD (including severe emphysema, chronic bronchitis), lung cancer and asthma.

The CompleClinical application from CompleWare is a comprehensive eClinical solution for clinical trial data capture and management. The VIDA|vision pulmonary suite of software and services provides full breadth and depth of analysis, empowering chest physicians with advanced, quantitative information to help inform care decisions. 

For more information: www.compleware.com, www.vidadiagnostics.com

Related Content

Oxipit Introduces Multilingual Support for ChestEye AI Imaging Suite
News | Artificial Intelligence | April 16, 2019
The CE-certified ChestEye artificial intelligence (AI) imaging suite by Oxipit is now available in seven European...
Enlitic Closes Series B Funding for Artificial Intelligence Solutions for Radiologists
News | Artificial Intelligence | April 08, 2019
Radiology artificial intelligence (AI) company Enlitic announced the close of its $15 million Series B financing round...
Technological Advancements Expected to Drive Virtual Reality Growth in Healthcare
News | Advanced Visualization | April 04, 2019
Increasing demand for innovative diagnostic techniques, neurological disorders and increasing disease awareness are...
Medivis Unveils AnatomyX Augmented Reality Education Platform
Technology | Advanced Visualization | April 02, 2019
Medical imaging and visualization company Medivis announced the launch of AnatomyX, its augmented reality (AR) platform...
Sponsored Content | Videos | Advanced Visualization | April 01, 2019
GE Healthcare goes beyond core equipment maintenance to help clients solve some of their most important asset and cli
Novarad Names New President
News | Enterprise Imaging | March 29, 2019
Medical imaging software company Novarad announced that it has appointed Paul Jensen as company president.
NZ Technologies Announces First Peer-Reviewed Paper on TIPSO AirPad
News | Interventional Radiology | March 25, 2019
NZ Technologies Inc. announced the first published clinical review on its TIPSO technology’s ability to provide...
Researchers Use Radiomics to Predict Who Will Benefit from Chemotherapy
News | Radiomics | March 21, 2019
Using data from computed tomography (CT) images, researchers may be able to predict which lung cancer patients will...
DrChrono and 3D4Medical Partner to Bring 3-D Interactive Modeling to Physician Practices
News | Advanced Visualization | March 18, 2019
DrChrono Inc. and 3D4Medical have teamed up so practices across the United States can access 3-D interactive modeling...
Jennifer N. A. Silva, M.D., a pediatric cardiologist at Washington University School of Medicine in Saint Louis, Mo., describes “mixed reality” at ACC19 Future Hub.

Jennifer N. A. Silva, M.D., a pediatric cardiologist at Washington University School of Medicine in Saint Louis, Mo., describes “mixed reality” at ACC19 Future Hub.

Feature | Cardiac Imaging | March 17, 2019 | By Greg Freiherr
Virtual reality (VR) and its less immersive kin, augmented reality (AR), are gaining traction in some medical applica